Home Cart Sign in  
Chemical Structure| 5631-70-9 Chemical Structure| 5631-70-9

Structure of 5,7,4'-Trimethoxyflavone
CAS No.: 5631-70-9

Chemical Structure| 5631-70-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

5,7,4'-Trimethoxyflavone can be isolated from the medicinal plant Kaempferia parviflora (KP). It acts as a CFTR activator with an EC50 of 64 μM.

Synonyms: 4',5,7-Trimethoxyflavone; 5,7,4'-Trimethoxyflavone; MTF

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 5,7,4'-Trimethoxyflavone

CAS No. :5631-70-9
Formula : C18H16O5
M.W : 312.32
SMILES Code : O=C1C=C(C2=CC=C(OC)C=C2)OC3=CC(OC)=CC(OC)=C13
Synonyms :
4',5,7-Trimethoxyflavone; 5,7,4'-Trimethoxyflavone; MTF
MDL No. :N/A
InChI Key :ZXJJBDHPUHUUHD-UHFFFAOYSA-N
Pubchem ID :79730

Safety of 5,7,4'-Trimethoxyflavone

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of 5,7,4'-Trimethoxyflavone

epigenetics
DNA
pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HT29 cells 40 µM 24 h TF decreases PD-L1 expression in a concentration- and time-dependent manner PMC11208742
RKO cells 20 µM 24 h TF decreases PD-L1 expression in a concentration- and time-dependent manner PMC11208742
Human dermal fibroblasts (HDFs) 6.25 and 12.5 µM 1 h TMF inhibited TNF-α-induced ROS generation PMC8533329
Human dermal fibroblasts (HDFs) 6.25 and 12.5 µM 24 h TMF inhibited MMP-1 expression and stimulated COLIA1 expression PMC8533329

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice MC38 xenograft tumors Intraperitoneal injection 12.5 or 25 mg/kg Daily for 12 days TF activates tumor-infiltrating T-cell immunity and reduces the immunosuppressive infiltration of myeloid-derived suppressor cells and regulatory T cells, thus exerting antitumor effects. PMC11208742

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.20mL

0.64mL

0.32mL

16.01mL

3.20mL

1.60mL

32.02mL

6.40mL

3.20mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories